Page 1 of Clinical Trials for Acorda Therapeutics [SPONSOR-COLLABORATORS], 21 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial
Last Updated: February 24, 2012
Condition(s): Multiple Sclerosis
2
Completed
Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Last Updated: June 23, 2005
Condition(s): Spinal Cord Injury; Muscle Spasticity
3
Completed
Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis
Last Updated: August 3, 2011
Condition(s): Multiple Sclerosis
4
Recruiting
A Phase 1/Phase 2 Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
Last Updated: May 23, 2012
Condition(s): Ischemic Stroke
5
Completed
Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis
Last Updated: March 1, 2012
Condition(s): Multiple Sclerosis
6
Completed
Study of Oral Fampridine-SR in Multiple Sclerosis
Last Updated: May 11, 2011
Condition(s): Multiple Sclerosis
7
Terminated
Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy
Last Updated: April 27, 2012
Condition(s): Spasticity Due to Cerebral Palsy
8
Recruiting
Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy
Last Updated: May 24, 2012
Condition(s): Cerebral Palsy (CP)
9
Completed
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Last Updated: April 14, 2011
Condition(s): Multiple Sclerosis
10
Completed
Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment
Last Updated: January 13, 2012
Condition(s): Renal Insufficiency
11
Active, not recruiting
An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)
Last Updated: May 4, 2012
Condition(s): Multiple Sclerosis
12
Active, not recruiting
Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis
Last Updated: March 26, 2012
Condition(s): Multiple Sclerosis
13
Recruiting
Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure
Last Updated: March 16, 2012
Condition(s): Heart Failure
14
Completed
Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial
Last Updated: February 24, 2012
Condition(s): Multiple Sclerosis
15
Recruiting
Dalfampridine for Imbalance in Multiple Sclerosis
Last Updated: October 6, 2011
Condition(s): Multiple Sclerosis; Fatigue
16
Active, not recruiting
Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-SR in Canadian Subjects With Multiple Sclerosis Who Participated in Acorda Extension Trials.
Last Updated: December 1, 2011
Condition(s): Multiple Sclerosis
17
Not yet recruiting
A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease
Last Updated: December 13, 2011
Condition(s): Parkinson's Disease; Gait Disorders
18
Recruiting
A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis
Last Updated: June 3, 2011
Condition(s): Multiple Sclerosis
19
Not yet recruiting
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis
Last Updated: March 28, 2012
Condition(s): Transverse Myelitis
20
Completed
A PK and Safety Study of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy Volunteers
Last Updated: November 17, 2011
Condition(s): Healthy

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Acorda+Therapeutics

Page 1 of Clinical Trials for Acorda Therapeutics [SPONSOR-COLLABORATORS], 21 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About